157 related articles for article (PubMed ID: 36467422)
1. Long-term efficacy and safety of sirolimus for retinal astrocytic hamartoma associated with tuberous sclerosis complex.
Zhang CX; Xu KF; Long Q; Zhang X; Yang ZK; Dai RP; Zhang ZQ
Front Cell Dev Biol; 2022; 10():973845. PubMed ID: 36467422
[TBL] [Abstract][Full Text] [Related]
2. Mammalian target of rapamycin inhibitors for the treatment of astrocytic hamartoma in tuberous sclerosis complex (TSC).
Vorobichik Berar O; Tzadok M; Zloto O; Moroz I; Hecht I; Musika AA; Shlomovitz O; Fabian ID; Vishnevskia Dai V
Graefes Arch Clin Exp Ophthalmol; 2022 Sep; 260(9):3061-3068. PubMed ID: 35230473
[TBL] [Abstract][Full Text] [Related]
3. [The fundus autofluorescence of retinal astrocytic hamartomas in tuberous sclerosis complex].
Zhang CX; Zhang ZQ; Xu KF; Long Q; Yang ZK; Dai RP; Du H; Li DH
Zhonghua Yan Ke Za Zhi; 2020 Mar; 56(3):211-216. PubMed ID: 32187950
[No Abstract] [Full Text] [Related]
4. Clinical features and optical coherence tomography findings of retinal astrocytic hamartomas in Chinese patients with tuberous sclerosis complex.
Zhang C; Xu K; Long Q; Yang Z; Dai R; Du H; Li D; Zhang Z
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):887-892. PubMed ID: 31897702
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Aggressive Retinal Astrocytic Hamartoma with Oral Mechanistic Target of Rapamycin Inhibition.
Wu F; McGarrey MP; Geenen KR; Skalet AH; Guillot FH; Wilson JL; Shah AS; Gonzalez E; Thiele EA; Kim IK; Aronow ME
Ophthalmol Retina; 2022 May; 6(5):411-420. PubMed ID: 35007768
[TBL] [Abstract][Full Text] [Related]
6. Retinal astrocytic hamartoma in tuberous sclerosis complex in an elderly person: a case report.
Qin X; Tao Y; Zhang Z
BMC Ophthalmol; 2018 Dec; 18(1):319. PubMed ID: 30541513
[TBL] [Abstract][Full Text] [Related]
7. Retinal Astrocytic Hamartoma Arises in Nerve Fiber Layer and Shows "Moth-Eaten" Optically Empty Spaces on Optical Coherence Tomography.
Shields CL; Say EAT; Fuller T; Arora S; Samara WA; Shields JA
Ophthalmology; 2016 Aug; 123(8):1809-1816. PubMed ID: 27157148
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of adult patient with neurofibromatosis type 1 with retinal astrocytic hamartoma using spectral-domain optical coherence tomography: a review of the literature and a report of a case.
Abdolrahimzadeh S; Formisano M; Scuderi L; Rahimi S
Ophthalmic Genet; 2021 Apr; 42(2):209-215. PubMed ID: 33203322
[No Abstract] [Full Text] [Related]
9. Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience.
Krueger DA; Capal JK; Curatolo P; Devinsky O; Ess K; Tzadok M; Koenig MK; Narayanan V; Ramos F; Jozwiak S; de Vries P; Jansen AC; Wong M; Mowat D; Lawson J; Bruns S; Franz DN;
Eur J Paediatr Neurol; 2018 Nov; 22(6):1066-1073. PubMed ID: 30005812
[TBL] [Abstract][Full Text] [Related]
10. An atypical presentation of retinal astrocytic hamartoma with co-occurring SEGA in a tuberous sclerosis patient.
Patra S; Patra SS
Radiol Case Rep; 2024 Mar; 19(3):1046-1050. PubMed ID: 38226050
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Color Fundus Photography, Infrared Fundus Photography, and Optical Coherence Tomography in Detecting Retinal Hamartoma in Patients with Tuberous Sclerosis Complex.
Bai DY; Wang X; Zhao JY; Li L; Gao J; Wang NL
Chin Med J (Engl); 2016 May; 129(10):1229-35. PubMed ID: 27174333
[TBL] [Abstract][Full Text] [Related]
12. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
MacKeigan JP; Krueger DA
Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
[TBL] [Abstract][Full Text] [Related]
13. CT characteristics predict the response to everolimus or sirolimus of renal angiomyolipomas in patients with tuberous sclerosis complex.
Wang W; Guo H; Shi B; Sun H; Li H; Zhang Y; Cai Y
Int Urol Nephrol; 2019 Apr; 51(4):671-676. PubMed ID: 30756282
[TBL] [Abstract][Full Text] [Related]
14. Image features of retinal astrocytic hamartoma in a patient with tuberous sclerosis complex.
Zhang P; Sun D; Zhu J; Li J; Wang Y
Eye Sci; 2014 Dec; 29(4):223-6. PubMed ID: 26016075
[TBL] [Abstract][Full Text] [Related]
15. Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China.
Luo C; Zhang YS; Zhang MX; Chen MF; Li Y; Qi L; Li HZ; Zu XB; Cai Y
Orphanet J Rare Dis; 2021 Jul; 16(1):299. PubMed ID: 34217357
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Kotulska K; Chmielewski D; Borkowska J; Jurkiewicz E; Kuczyński D; Kmieć T; Łojszczyk B; Dunin-Wąsowicz D; Jóźwiak S
Eur J Paediatr Neurol; 2013 Sep; 17(5):479-85. PubMed ID: 23567018
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Use-Long-term Follow-up of First Tuberous Sclerosis Complex Patient Treated De Novo With Sirolimus After Kidney Transplantation: A Case Report.
Tarasewicz A; Dębska-Ślizień A; Rutkowska B; Szurowska E; Matuszewski M
Transplant Proc; 2018; 50(6):1904-1909. PubMed ID: 30056926
[TBL] [Abstract][Full Text] [Related]
18. Retinal hamartomas at different stages in a patient with tuberous sclerosis: A OCT-SS description.
Dias PB; Linhares ACB; Hokazono K
Clin Case Rep; 2023 Nov; 11(11):e8185. PubMed ID: 38028108
[TBL] [Abstract][Full Text] [Related]
19. Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus.
Doğan V; Yeşil Ş; Kayalı Ş; Beken S; Özgür S; Ertuğrul İ; Bozkurt C; Örün UA; Karademir S
J Trop Pediatr; 2015 Feb; 61(1):74-7. PubMed ID: 25344617
[TBL] [Abstract][Full Text] [Related]
20. Long Term Outcome and Histologic Findings of a Retinal Astrocytic Hamartoma Treated with Intravitreal Injection of Anti-VEGF: A Case Report.
Ahmad KT; Mansour HA; Rollins BT; Oviedo SP; Phillips PH; Uwaydat SH
Case Rep Ophthalmol Med; 2021; 2021():7500791. PubMed ID: 34603809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
